Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Increased vessel perfusion predicts the efficacy of immune checkpoint blockade
Xichen Zheng, Zhaoxu Fang, Xiaomei Liu, et al.
Journal of Clinical Investigation (2018) Vol. 128, Iss. 5, pp. 2104-2115
Open Access | Times Cited: 195

Showing 1-25 of 195 citing articles:

Improving cancer immunotherapy using nanomedicines: progress, opportunities and challenges
John D. Martin, Horacio Cabral, Triantafyllos Stylianopoulos, et al.
Nature Reviews Clinical Oncology (2020) Vol. 17, Iss. 4, pp. 251-266
Open Access | Times Cited: 544
The hallmarks of successful anticancer immunotherapy
Lorenzo Galluzzi, Timothy A. Chan, Guido Kroemer, et al.
Science Translational Medicine (2018) Vol. 10, Iss. 459
Open Access | Times Cited: 493
The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies
Florent Petitprez, Maxime Meylan, Aurélien de Reyniès, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 476
Combination of anti-angiogenic therapy and immune checkpoint blockade normalizes vascular-immune crosstalk to potentiate cancer immunity
Won Suk Lee, Hannah Yang, Hong Jae Chon, et al.
Experimental & Molecular Medicine (2020) Vol. 52, Iss. 9, pp. 1475-1485
Open Access | Times Cited: 473
Dual Programmed Death Receptor‐1 and Vascular Endothelial Growth Factor Receptor‐2 Blockade Promotes Vascular Normalization and Enhances Antitumor Immune Responses in Hepatocellular Carcinoma
Kohei Shigeta, Meenal Datta, Tai Hato, et al.
Hepatology (2019) Vol. 71, Iss. 4, pp. 1247-1261
Open Access | Times Cited: 359
The Current Landscape of Immune Checkpoint Blockade in Hepatocellular Carcinoma
Matthias Pinter, Rakesh K. Jain, Dan G. Duda
JAMA Oncology (2020) Vol. 7, Iss. 1, pp. 113-113
Open Access | Times Cited: 266
Metabolic interventions in the immune response to cancer
David O’Sullivan, David E. Sanin, Edward J. Pearce, et al.
Nature reviews. Immunology (2019) Vol. 19, Iss. 5, pp. 324-335
Closed Access | Times Cited: 239
Combining microenvironment normalization strategies to improve cancer immunotherapy
Fotios Mpekris, Chrysovalantis Voutouri, James W. Baish, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 7, pp. 3728-3737
Open Access | Times Cited: 233
Augmenting Anticancer Immunity Through Combined Targeting of Angiogenic and PD-1/PD-L1 Pathways: Challenges and Opportunities
Stephen P. Hack, Andrew X. Zhu, Yulei Wang
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 204
Anti-angiogenic Agents in Combination With Immune Checkpoint Inhibitors: A Promising Strategy for Cancer Treatment
Yuxiao Song, Yang Fu, Qi Xie, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 203
Hypoxia as a driver of resistance to immunotherapy
Joanna Kopecka, Iris C. Salaroglio, Elisabeth Pérez-Ruíz, et al.
Drug Resistance Updates (2021) Vol. 59, pp. 100787-100787
Open Access | Times Cited: 177
The Tumor Vascular Endothelium as Decision Maker in Cancer Therapy
Diana Klein
Frontiers in Oncology (2018) Vol. 8
Open Access | Times Cited: 173
Vascular regulation of antitumor immunity
Lance L. Munn, Rakesh K. Jain
Science (2019) Vol. 365, Iss. 6453, pp. 544-545
Open Access | Times Cited: 166
Radiotherapy, immunotherapy, and the tumour microenvironment: Turning an immunosuppressive milieu into a therapeutic opportunity
NE Donlon, Robert Power, Conall Hayes, et al.
Cancer Letters (2021) Vol. 502, pp. 84-96
Open Access | Times Cited: 135
Strategies to Improve the Antitumor Effect of Immunotherapy for Hepatocellular Carcinoma
Rui Xing, Jinping Gao, Qi Cui, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 127
Tumor microenvironment and radioresistance
Tatsuya Suwa, Minoru Kobayashi, Jin‐Min Nam, et al.
Experimental & Molecular Medicine (2021) Vol. 53, Iss. 6, pp. 1029-1035
Open Access | Times Cited: 117
Role of interferon-gamma (IFN-γ) and IFN-γ receptor 1/2 (IFNγR1/2) in regulation of immunity, infection, and cancer development: IFN-γ-dependent or independent pathway
Huihui Ding, Gongfu Wang, Zhen Yu, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 155, pp. 113683-113683
Open Access | Times Cited: 77
Coagulome and the tumor microenvironment: an actionable interplay
Antoine Galmiche, Janusz Rak, Lubka T. Roumenina, et al.
Trends in cancer (2022) Vol. 8, Iss. 5, pp. 369-383
Open Access | Times Cited: 74
PHGDH-mediated endothelial metabolism drives glioblastoma resistance to chimeric antigen receptor T cell immunotherapy
Duo Zhang, Albert M. Li, Guanghui Hu, et al.
Cell Metabolism (2023) Vol. 35, Iss. 3, pp. 517-534.e8
Closed Access | Times Cited: 64
New clinical trial design in precision medicine: discovery, development and direction
Xiao-Peng Duan, Bao‐Dong Qin, Xiao‐Dong Jiao, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 53
Antiangiogenic–immune-checkpoint inhibitor combinations: lessons from phase III clinical trials
Hung‐Yang Kuo, Kabir A. Khan, Robert S. Kerbel
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 6, pp. 468-482
Closed Access | Times Cited: 33
TET2-mediated tumor cGAS triggers endothelial STING activation to regulate vasculature remodeling and anti-tumor immunity in liver cancer
Hongwei Lv, Qianni Zong, Cian Chen, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 31
Mechanisms, combination therapy, and biomarkers in cancer immunotherapy resistance
Manshi Yang, Mengying Cui, Yang Sun, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 17
Milestones in tumor vascularization and its therapeutic targeting
Michele De Palma, Douglas Hanahan
Nature Cancer (2024) Vol. 5, Iss. 6, pp. 827-843
Closed Access | Times Cited: 17
New insight in immunotherapy and combine therapy in colorectal cancer
Kai Ji, Hang Jia, Zixuan Liu, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 12
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top